• Wed, April 19, 2023

Keay Nakae Maintained (SONN) at Strong Buy on, Apr 19th, 2023

Keay Nakae of Chardan Capital, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Apr 19th, 2023.

Keay, nor any peers, have made any analyst calls on SONN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30